Latest Articles
-
Is An Earnings Beat In The Cards For Medtronic Stock?
Medtronic (NYSE: MDT) is scheduled to report its fiscal 2025 first-quarter results on Tuesday, August 20 (fiscal year ends in April). We expect Medtronic stock to trade higher post-Q1 results announcement, with its revenues and earnings expected ...
-
With Less Than 10% Contribution To Sales How Important Is The Diabetes Segment For Medtronic Stock?
Medtronic’s (NYSE: MDT) diabetes segment, which sells insulin pumps, continuous glucose monitoring (CGM) systems, and consumables has seen its revenue rise at a slower pace of 1.4% annually from $2.4 billion in fiscal 2020 (fiscal ends...
-
Will Medtronic Stock See Higher Levels Post Q4 Results After 5% Gains This Year?
Medtronic (NYSE: MDT) is scheduled to report its fiscal 2024 fourth-quarter results on Thursday, May 23 (fiscal ends in April). We expect Medtronic stock to trade sideways post-Q4 results announcement, with its revenues and earnings expected to m...
-
What’s Next For Medtronic Stock After An Upbeat Q3?
Medtronic (NYSE: MDT) recently reported its Q3 fiscal 2024 results (fiscal ends in April), with revenues and earnings beating the street estimates. The company reported revenue of $8.1 billion and adjusted earnings of $1.30 per share compared ...
-
Up Just 6% In 2023 Is Medtronic Stock A Better Pick Over Abbott?
Given its better prospects, we believe Medtronic stock (NYSE: MDT) is a better pick than its peer, Abbott stock (NYSE: ABT). Abbott trades at a higher valuation multiple of 4.9x revenues vs. 3.6x for Medtronic, partly due to its superior re...
-
Should You Pick Medtronic Stock At $80 After An Upbeat Q2?
Medtronic (NYSE: MDT) recently reported its Q2 fiscal 2024 results (fiscal ends in April), with revenues and earnings beating our estimates, and we believe that MDT stock is undervalued, as discussed below. The company reported revenue of $8.0...
-
After A 6% Rise This Month Should You Pick Medtronic Stock Ahead of Its Q2?
Medtronic (NYSE: MDT) is scheduled to report its fiscal 2024 second-quarter results on Tuesday, November 21. We expect Medtronic stock to trade sideways post-Q2 results announcement, with its revenues and earnings expected to miss the street esti...
-
Should You Buy Medtronic Stock After A Q1 Beat?
Medtronic stock (NYSE: MDT) gained 2% in a week, faring slightly better than the broader S&P500 index, up 0.5%. Medtronic recently reported its Q1 fiscal 2024 (fiscal ends in April) results, which were better than the street estimates. Desp...
-
Will Medtronic Stock Rebound To Its Pre-Inflation Shock Highs?
Medtronic stock (NYSE: MDT) currently trades at $87 per share, roughly 27% below its level in March 2021, and it has the potential for sizable gains. MDT saw its stock trading at around $90 in late June 2022, just before the Fed started increas...
-
What’s Next For Medtronic Stock After A 9% Fall In A Week?
Medtronic stock (NYSE: MDT) is down 9% in a week, underperforming the broader markets, with the S&P500 up 0.4%. Although the company posted upbeat Q1 results last week, the stock has declined due to lower-than-expected guidance for fiscal 2...
-
What To Expect From Medtronic’s Q4?
Medtronic (NYSE: MDT) is scheduled to report its fiscal 2023 fourth-quarter results on Thursday, May 25. We expect Medtronic stock to trade sideways post-Q4 results announcement, with its revenues and earnings expected to align with the street es...
-
Will Medtronic Stock See Higher Levels After An Upbeat Q3?
Medtronic stock (NYSE: MDT) has risen 4% in a month, compared with -0.6% returns for the broader S&P500 index. Medtronic recently reported its Q3FY23 results, with revenue and earnings falling above our estimates. Despite its recent rise, ...
-
Here’s What To Expect From Medtronic’s Q3
Medtronic (NYSE: MDT) is scheduled to report its fiscal 2023 third-quarter results on Tuesday, February 21. We expect Medtronic stock to trade higher post Q3, with its revenues and earnings likely falling above the street estimates. The company s...
-
This Robotic Products Company Is A Better Pick Over Medtronic Stock
We believe Intuitive Surgical stock (NASDAQ: ISRG) is currently a better pick than Medtronic stock (NYSE: MDT), given its better prospects. Although Medtronic is trading at a comparatively lower valuation of 3.4x trailing revenues vs. 15.4x...
-
Should You Buy Medtronic Stock At $80?
Medtronic stock (NYSE: MDT) has declined 5% in a week, while it’s down 7% in a month, underperforming the broader markets with the S&P500 index rising 6% in a month. The recent fall can be attributed to the Q2FY23 results the company repor...
